Amniotics AB (OSTO:AMNI) Interest Expense : kr-1.19 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Amniotics AB Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Amniotics AB's interest expense for the three months ended in Dec. 2023 was kr -0.36 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was kr-1.19 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Amniotics AB's Operating Income for the three months ended in Dec. 2023 was kr -5.47 Mil. Amniotics AB's Interest Expense for the three months ended in Dec. 2023 was kr -0.36 Mil. Amniotics AB did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Amniotics AB Interest Expense Historical Data

The historical data trend for Amniotics AB's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amniotics AB Interest Expense Chart

Amniotics AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

-1.39

-1.90

Amniotics AB Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial										-0.64	-0.64	-0.19	-0.64	-0.36

Amniotics AB Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.19 Mil.

Amniotics AB (OSTO:AMNI) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Amniotics AB's Interest Expense for the three months ended in Dec. 2023 was kr-0.36 Mil. Its Operating Income for the three months ended in Dec. 2023 was kr-5.47 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was kr0.00 Mil.

Amniotics AB's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Amniotics AB did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Amniotics AB (OSTO:AMNI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amniotics AB (OSTO:AMNI) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

66J:Germany

Address

Scheelevagen 2, Lund, SWE, 223 63

Website

https://www.amniotics.com

Amniotics AB is a biopharma company focusing on mesenchymal stem cells from amniotic fluid. It provides a novel platform for the production of medically superior mesenchymal stem cells including ethical and medically sound bio-banking opportunities for the newborn.